Q/C Technologies, Inc. Payments of Derivative Issuance Costs
Q/C Technologies, Inc. (QCLS) reported Payments of Derivative Issuance Costs of $762.83 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDerivativeIssuanceCosts · last filed 2025-08-19
- Q/C Technologies, Inc. payments of derivative issuance costs for the quarter ending 2025-06-30 was $0.00.
- Q/C Technologies, Inc. payments of derivative issuance costs for the quarter ending 2025-03-31 was $762.83K, a 0.00% change year-over-year.
- Q/C Technologies, Inc. payments of derivative issuance costs for the quarter ending 2024-12-31 was $0.00.
- Q/C Technologies, Inc. payments of derivative issuance costs for the quarter ending 2024-09-30 was $0.00.
- Q/C Technologies, Inc. payments of derivative issuance costs for fiscal 2024 was $762.83K, a 0.00% change from fiscal 2023.
- Q/C Technologies, Inc. payments of derivative issuance costs for fiscal 2023 was $762.83K.
| Period end | Payments of Derivative Issuance Costs 3 month | Payments of Derivative Issuance Costs 6 month | Payments of Derivative Issuance Costs 9 month | Payments of Derivative Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $762.83K 10-Q · filed 2025-08-19 | $762.83K derived: sum of 3 quarters · filed 2025-08-19 | $762.83K derived: sum of 4 quarters · filed 2025-08-19 |
| 2025-03-31 | $762.83K 10-Q · filed 2025-05-15 | $762.83K derived: sum of 2 quarters · filed 2025-05-15 | $762.83K derived: sum of 3 quarters · filed 2025-05-15 | $762.83K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-11 | $0.00 derived: sum of 2 quarters · filed 2025-04-11 | $0.00 derived: sum of 3 quarters · filed 2025-04-11 | $762.83K 10-K · filed 2025-04-11 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $762.83K 10-Q · filed 2024-11-14 | $762.83K derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $762.83K 10-Q · filed 2024-08-19 | $762.83K derived: sum of 3 quarters · filed 2024-08-19 | |
| 2024-03-31 | $762.83K 10-Q · filed 2024-05-15 | $762.83K derived: sum of 2 quarters · filed 2024-05-15 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $762.83K 10-K · filed 2024-04-01 | ||
| 2023-09-30 | $762.83K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |